Clinical Research Directory
Browse clinical research sites, groups, and studies.
Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
Sponsor: Bernard (Barry) Baumel
Summary
The purpose of this research study is to test if adding one infusion of mesenchymal stem cells to the current treatment with antipsychotic medication may help control behavioral problems in people with a diagnosis of moderate to severe Alzheimer's disease.
Official title: A Pilot Study to Assess the Effect of Adding 1 Infusion of Human Mesenchymal Stem Cells (hMSC) to the Treatment of Patients Suffering Agitation/Aggression or Other Behavioral Abnormalities From Alzheimer's Disease.
Key Details
Gender
All
Age Range
55 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2025-04-29
Completion Date
2026-06-15
Last Updated
2025-05-29
Healthy Volunteers
No
Conditions
Interventions
hMSC
Participants will come in person to receive one intravenous infusion of approximately 25 million cells up to 20 minutes.
Locations (1)
University of Miami Department of Neurology
Miami, Florida, United States